Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309515
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of glycosphingolipid and glycosylphosphatidylinositol (GPI) anchor glycosylation is a group of rare inherited metabolic conditions that affect how the body builds and attaches certain sugar-containing molecules to fats and proteins on cell surfaces. Glycosphingolipids are fatty molecules with sugar chains that sit on the outer surface of cells and play important roles in cell signaling, immune function, and nervous system development. GPI anchors are structures that attach specific proteins to the cell membrane, and these proteins are essential for many body functions including blood clotting, immune defense, and embryonic development. When the enzymes responsible for building these molecules do not work properly due to genetic mutations, a wide range of symptoms can occur. Because these molecules are found throughout the body, the effects can be multi-system. Common features may include intellectual disability, seizures, delayed development, distinctive facial features, skin abnormalities, and problems with blood clotting or the immune system. Some forms present at birth or in infancy, while others may appear later in childhood. Treatment is currently supportive and symptom-based, as there are no approved curative therapies for this group of disorders. Management typically involves a team of specialists who address seizures, developmental delays, and other organ-specific problems. Research is ongoing to better understand these conditions and develop targeted treatments.

Also known as:

Key symptoms:

Intellectual disabilitySeizures or epilepsyDelayed speech and language developmentDelayed motor milestones such as sitting and walkingDistinctive facial featuresLow muscle tone (floppiness)Skin abnormalitiesBlood clotting problemsFrequent infections due to immune system issuesHearing lossVision problemsShort stature or growth delaysAbnormalities of fingers or toesLiver or kidney problemsFeeding difficulties in infancy

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.

View clinical trials →

No actively recruiting trials found for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation community →

No specialists are currently listed for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylationForum →

No community posts yet. Be the first to share your experience with Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.

Start the conversation →

Latest news about Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation

No recent news articles for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic subtype does my child have, and what does that mean for their outlook?,What seizure medications are most appropriate, and what side effects should I watch for?,Are there any clinical trials or experimental treatments available for this condition?,What developmental therapies should we start, and how often?,How will this condition affect my child's learning and what educational supports are available?,Should other family members be tested for this genetic condition?,What emergency situations should I be prepared for, and what is the action plan?

Common questions about Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation

What is Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation?

Disorder of glycosphingolipid and glycosylphosphatidylinositol (GPI) anchor glycosylation is a group of rare inherited metabolic conditions that affect how the body builds and attaches certain sugar-containing molecules to fats and proteins on cell surfaces. Glycosphingolipids are fatty molecules with sugar chains that sit on the outer surface of cells and play important roles in cell signaling, immune function, and nervous system development. GPI anchors are structures that attach specific proteins to the cell membrane, and these proteins are essential for many body functions including blood